FDA Warning Letter — Takeda Pharmaceutical Company Limited
The FDA took a Warning Letter action against Takeda Pharmaceutical Company Limited on June 10, 2020 (Hikari, Japan). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Takeda Pharmaceutical Company Limited
- Date
- June 10, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Hikari (Japan)